Abstract:Two choices are widely used for radiation delivery in China, 3-dimensional conformal radiation therapy (3D-CRT) and conventional external beam radiation and neutron brachytherapy (EBRT+NBT). No randomized comparisons have been conducted in the setting of esophageal cancer. We analyzed two cancer center a large cohort of localized esophageal squamous cell carcinoma (ESCC) patients treated from 3D-CRT to EBRT+NBT to compare outcomes. Patients with ESCC treated with definitive radiation at two institutions between 2002 and 2012 were retrospectively reviewed. Multivariable Cox regression was used to compare oncologic outcomes of NBT+EBRT and 3D-CRT in the context of other clinically relevant variables. Acute and chronic toxicities associated with the 2 techniques were compared using Fisher exact and log-rank tests, respectively. A total of 884 patients were treated during the study period, there were 583 men and 301 women. 339 and 545 underwent 3DCRT NBT+EBRT. The median age was 66 years (range, 36-93 years). Median follow-up time was 32 months, respectively. The overall median survival was 20.3 months. Three and 5-year OS rates were 37.2% and 26.6%, respectively. 5-y LC rate for the whole group was 47.1%. Radiation modality was associated significantly with differences in OS or LC in either multivariable or univariable analyses. To further confirm the treatment modality as a prognostic factor, we compared the two subgroups of patients who were tested to be early-stage (I+II) or advanced stage (III). In the stage I+II group, the 5-year OS and LC rate in the patients who were treated with 3D-CRT were significantly lower than the patients who were treated with EBRT+NBT (with p = 0.004 and 0.045, respectively, for OS and LC). In the stage III group, the differences in 5-year OS rate and LC rate between the two treatment modalities were less obvious (with p=0.306 and 0.175, respectively, for OS and LC). There were 195 recurrences (35.7%), among which 170 (31.2%) were in-field recurrences and 25 (4.6%) were out-of-field recurrences. In terms of acute toxicity, no perforations were observed during this treatment period. Among which the NBT+EBRT group have significantly higher rate of leukopenia and thrombocytopenia (with p<0.001 for both). For late toxicity, fistula and massive bleeding were observed in both groups of patients, of which the 3D-CRT group show higher rate on both effects. In this cohort of patients with ESCC treated with NBT+EBRT were associated with better oncologic outcomes than those of 3D-CRT. NBT+EBRT were associated with a higher rate of acute irradiation toxicity. 3D-CRT has the higher rate of late toxicity esophageal fistulas.

External beam radiotherapy with or without californium-252 neutron brachytherapy for treatment of recurrence after definitive chemoradiotherapy

Safety and Outcome of External Beam Radiation and Neutron Brachytherapy in Elderly Patients with Esophageal Squamous Cell Cancer

A Retrospective Study of External Beam Radiation, Neutron Brachytherapy, and Concurrent Chemotherapy for Patients with Localized Advanced Carcinoma of the Esophagus

A Retrospective Study of Comparison of Two Common Radiation Therapy Techniques for Definitive Treatment of Localized Esophageal Squamous Cell Cancer

A Retrospective Study of Californium-252 Neutron Brachytherapy Combined with EBRT Versus 3D-CRT in the Treatment of Esophageal Squamous Cell Cancer

A Prospective Study of Radical External Beam Radiotherapy Versus External Beam Radiotherapy Combined with Intraluminal Brachytherapy for Primary Esophageal Cancer

External beam radiation and high-dose-rate brachytherapy for elderly patients with gastroesophageal junction adenocarcinoma.

A Clinical Observation of Cf-252 Intracavitary Radiation Combined with External-beam Irradiation in the Treatment of Esophageal Carcinoma

Intraluminal high dose rate brachytherapy combined with external beam irradiation in carcinoma of esophagus

Systematic Review of External Beam Radiotherapy Plus Brachytherapy in Treatment of Patients with Inoperable Esophageal Cancer

The Safety and Usefulness of Neutron Brachytherapy and External Beam Radiation in the Treatment of Patients with Gastroesophageal Junction Adenocarcinoma with or Without Chemotherapy

Re-irradiation with or Without Chemotherapy for In-field Local Recurrence among Esophageal Cancer Patients after Initial Definitive Concurrent Chemo-radiotherapy

Californium-252 neutron brachytherapy combined with external pelvic radiotherapy plus concurrent chemotherapy for cervical cancer: a retrospective clinical study

Definitive chemoradiotherapy versus neoadjuvant chemoradiotherapy followed by surgery in patients with locally advanced esophageal squamous cell carcinoma who achieved clinical complete response when induction chemoradiation finished: A phase II random

Concurrent chemoradiotherapy for cervical esophageal squamous cell carcinoma: treatment results from a prospective observational study.

Californium-252 Neutron Intraluminal Brachytherapy for Treatment of 62 Cases Cervical Carcinoma

The Role of High-dose-rate Brachytherapy (HDR-BT) in the Radiotherapy of Esophageal Carcinoma

Retrospective Analysis on Results of Late Course Accelerated Hyperfractionation Radiotherapy and Conventional Fractionation Radiotherapy Plus Brachytherapy for Esophageal Carcinoma

Long Term Results of Different Radiotherapy Techniques and Fractions for Esophageal Squamous Cell Carcinoma

The Evolving Strategy of Californium-252 Neutron Intracavitary Brachytherapy in Treating Patients With Low-Lying T2 or T3 Rectal Adenocarcinoma: From Fixed to Individualized Regime With Intrarectal Peritumoral Injection of Amifostine

Cmar_a_256680 5293..5299